Juillerat-Jeanneret_2017_Expert.Opin.Ther.Targets_21_977

Fibroblast activation protein-alpha (FAP-alpha) belongs to the family of prolyl-specific serine proteases. FAP-alpha displays both exopeptidase and endopeptidase/gelatinase/collagenase activities. FAP-alpha protein and/or activity have been associated with fibrosis, inflammation and cancer, but the protein is undetectable in most normal tissues. FAP-alpha is selectively expressed at sites of tissue remodeling and repair and enhances tumor progression, suggesting that this protease may be a therapeutic target to treat human disorders associated with fibrotic dysregulation. Areas covered: In this review, we summarize the mechanisms driving tissue fibrosis and describe some of the enzymes involved in fibrosis, concentrating on FAP-alpha. We describe its enzymatic properties, discuss the tools developed to control its activity and the problem of selectivity toward the other proteases of the family and outline its potential biological substrates. We also consider non-enzymatic functions of this protein and suggest that repression of FAP-alpha expression may represent therapeutic options. Expert opinion: Questions remain regarding the biological functions of FAP-alpha, either dependent or independent of its enzyme activity. However, as progress is underway to develop FAP-alpha-specific inhibitors and therapeutic antibodies, its role in diseases associated with fibrosis is starting to emerge, ultimately leading to novel therapeutic options for inflammatory and oncologic diseases.